Johnson Outdoors weathers cyclical challenges with a strong balance sheet. See more on JOUT's long-term outdoor recreation ...

Johnson & Johnson is a diversified healthcare giant. J&J has increased its dividend for 63 consecutive years. One high-yield ...

Explore Johnson Outdoors' Q2 2025 earnings analysis, modest cost savings, tariff risks, and valuation concerns leading to a ...

Johnson & Johnson (NYSE:JNJ) recently announced promising Phase 1 study results for Pasritamig, a novel antibody for advanced ...

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

So I won't buy Johnson & Johnson, because it would basically be repeating the mistake I made with 3M. I don't have the fortitude to own stock in a company facing a major problem that it can't talk ...

Johnson & Johnson (NYSE:JNJ) is one of the best stocks for a retirement stock portfolio. On June 12, UBS global equity ...

The board of Johnson Controls has approved a $9 billion share-repurchase program. The Cork, Ireland-based building company said Friday that the new buyback plan stacks on top of $1.1 billion in ...

Market downturns are buying opportunities for profitable, growing companies with strong business models. Healthcare is a ...